Skip to main content
. 2020 Dec 9;10:21521. doi: 10.1038/s41598-020-76504-5

Figure 2.

Figure 2

X-ray diffraction patterns for (A) iron oxide nanoparticles; (B) MLDH; (C) pure sorafenib; (D) pure PEG; (E) core–shell nanoparticles (FPEGSO-MLDH); (F) pure PVA; (G) core–shell nanoparticles (FPVASO-MLDH). Inset shows the XRD patterns of (H) FPEGSO and (I) FPVASO.